Cereton solution 250mg/ml 4ml #5

Cereton solution instruction for use

Reed more and buy Cereton solution on this page

Composition

1 ampoule (4 ml) of Cereton solution contains glycerylphosphorylcholine hydrate as an active substance in terms of anhydrous glycerylphosphorylcholine (choline alphoscerate) - 1000 mg,
excipients: water for injection - up to 4 ml.
Description: clear colorless liquid
Pharmacotherapeutic group:
nootropic agent
ATX code: N07AX02

Pharmacodynamics

Cereton solution is nootropic agent. Central holostimulyator, which contains 40.5% of metabolically protected choline. Metabolic protection contributes to the release of choline in the brain. It provides the synthesis of acetylcholine and phosphatidylcholine in neuronal membranes, improves blood flow and enhances metabolic processes in the central nervous system, activates the reticular formation. Increases linear blood flow rate on the side of traumatic brain damage, contributes to the normalization of the spatial and temporal characteristics of spontaneous bioelectric brain activity, regression of focal neurological symptoms and recovery of consciousness; It has a positive effect on the cognitive and behavioral reactions of patients with vascular diseases of the brain (dyscirculatory encephalopathy and residual cerebrovascular events). It has a preventive and corrective effect on the pathogenetic factors of involutional psychoorganic syndrome, changes the phospholipid composition of neuronal membranes and reduces cholinergic activity. Stimulates the dose-dependent release of acetylcholine under physiological conditions; participating in the synthesis of phosphatidylcholine (membrane phospholipid), improves synaptic transmission, plasticity of neuronal membranes, receptor function. Does not affect the reproductive cycle and does not have a teratogenic, mutagenic effect.

Pharmacokinetics

It easily penetrates the blood-brain barrier, 85% is excreted by the lungs as carbon dioxide, the rest (15%) is excreted by the kidneys and through the intestines.

Cereton solution, Indications for use

    acute and recovery periods of severe craniocerebral injury and ischemic stroke, recovery period of hemorrhagic stroke, occurring with focal hemispheric symptoms or symptoms of a brain stem lesion;
    psychoorganic syndrome on the background of degenerative and involutional changes in the brain;
    cognitive disorders (mental function, memory, confusion, disorientation, reduced motivation, initiative and ability to concentrate), including dementia and encephalopathy;
    senile pseudomelancholia

Contraindications for Cereton solution

    hypersensitivity to Cereton solution or its components
    pregnancy;
    breastfeeding period

Dosage and administration

For acute conditions, they are administered intravenously (slowly) or deeply intramuscularly in doses of 1000 mg (1 ampoule) per day for 10–15 days.

Side effect

Nausea may occur (mainly as a consequence of dopaminergic activation), in which case the dose of Cereton solution is reduced.
Allergic reactions.

Overdose

Nausea may occur. Treatment: symptomatic therapy.

Interaction Cereton solution with other drugs

No significant interactions with other drugs have been identified.

special instructions

Cereton solution does not affect the speed of psychomotor reactions

Release form

Solution for intravenous and intramuscular administration of 250 mg / ml. On 4 ml in ampoules.
On 3 or 5 ampoules in a blister packaging. On 1 blister strip packaging together with the application instruction in a pack from a cardboard.

Storage conditions

List B. Store in a dark place at a temperature not higher than 25 degrees. Keep out of the reach of children.
Shelf life - 5 years. Do not use after the expiration date printed on the package.

Terms of sell

You don't need a prescription to buy Cereton solution.